|RxNews Recap for 05-18-11|
|By Staff and Wire Reports|
|Wednesday, 18 May 2011 19:56|
Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), a late-stage drug development company specialized in oncology and endocrine therapy, today reported financial and operating results as at and for the first quarter ended March 31, 2011.
Bio-AMD, Inc.(OTCBB: BIAD) today announced that FINRA has approved the Company's previously reported name change from Flex Fuels Energy, Inc. to Bio-AMD, Inc. and a trading symbol change from "FXFL" to "BIAD."
BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will present a company update at the UBS Global Specialty Pharmaceuticals Conference in London on Wednesday, May 25, 2011 at 9:30 a.m. GMT.
Callidus Software, Inc. (NASDAQ: CALD) today announced that it has priced $70 million principal amount of 4.75% convertible senior notes due 2016.
Elysium Internet, Inc. DBA www.TheDirectory.com (PINKSHEETS: EYSM), an emerging leader in the Local Business Search market, today announced that it has signed an agreement to monetize its legal related websites and that the Company is on track to post its seventh consecutive month of top line revenue growth.
FluoroPharma Medical (OTC.BB: CEWM) announced that it has completed a merger transaction with Commercial E Waste Management (CEWM).
Given Imaging (NASDAQ: GIVN) today announced that company management will present at the following investor conferences: The ThinkEquity 2nd Annual Healthcare Conference in New York City on Wednesday, May 25, 2011.
HWI Global, Inc., (OTCBB: IVTW), the Pittsburgh-based clean room design builder, announces plans to enter a joint venture with two well-established Middle East firms, ASCI Ltd. and Energy International Corporation (EIC).
Healthnostics, Inc. (PINKSHEETS: HNSS) previously issued guidance regarding short-sales of Healthnostics, Inc. common stock.
This morning's announcement that Northwest Biotherapeutics (OTCBB: NWBO) is partnering with Fraunhofer, the largest applied research foundation in Europe is significant in several ways.
Northwest Biotherapeutics (OTC Bulletin Board:NWBO) announced today that it is partnering with Fraunhofer for production of DCVax®-L for brain cancer, for clinical trials and compassionate use cases in Europe.
Novadaq® Technologies Inc. (TSX:NDQ), a developer of real-time medical imaging systems for use in the operating room, today announced that Dr. Arun Menawat, the Company's President and Chief Executive Officer, will present at BioFinance 2011 on Wednesday, June 1, at 11:45 a.m. Eastern Time.
NXP Semiconductors N.V. (NASDAQ: NXPI) will demonstrate a component for a complete, mixed signal, Base Transceiver Station (BTS) radio at the IEEE International Microwave Symposium (IMS 2011) to be held June 5-10 in Baltimore, Maryland (booth #420).
Oclaro, Inc. (NASDAQ:OCLR), a tier-one provider of optical communications and laser solutions, today announced that its 9xx nm high-power laser diode bars have been selected by Pantec Biosolutions, the leading provider of epidermal medical applications, for use in its next generation P.L.E.A.S.E.® (Precise Laser Epidermal System) platform.
Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, announced today that it was chosen to present at The 1st Asia Pacific Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension in Shanghai, China.
Radient Pharmaceuticals Corporation "RPC" (NYSE Amex: RPC), a developer and global marketer of In Vitro Diagnostic (IVD) cancer tests, today announced the Company will exhibit its FDA-cleared Onko-Sure® cancer test at the 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from June 3‐6, 2011.
Therma-Med, Inc. (PINKSHEETS: THRA) ("the Company") would like to announce it has signed an LOI to purchase Interest in Silver property in British Columbia, Canada.